Ipamorelin is a selective growth hormone secretagogue that stimulates the release of GH from the pituitary gland in a pulsatile manner
It has not received FDA approval for any indication
Orforglipron vs Tirzepatide: Pill vs Shot Orforglipron vs tirzepatide: 12.4% weight loss for the oral GLP-1 pill vs 22.5% for tirzepatide
Consider the injection day strategy
FIGURE 8 Atherosclerosis, a chronic inflammatory disease, may be an ideal environment for the high viral replication capabilities of SARS-CoV-2 in human cells, enhancing hyper-inflammation secondary to immune system dysregulation (Figure 9) that leads to adverse outcomes, as shown in patients with cardiovascular risk factors (258, 259)
The ideal scenario: use tirzepatide to reach a healthier weight, stop the medication with adequate washout time, conceive at a lower BMI, and benefit from improved metabolic health throughout the pregnancy